Literature DB >> 15196821

Efficacy of ganciclovir and cidofovir against human cytomegalovirus replication in SCID mice implanted with human retinal tissue.

Deborah J Bidanset1, Rachel J Rybak, Caroll B Hartline, Earl R Kern.   

Abstract

For immunocompromised hosts, human cytomegalovirus (CMV) can be a serious problem. For evaluation of antivirals used to treat CMV retinitis, we have used severe combined immunodeficient mice as hosts for human retinal tissue implanted in the eye and subsequently infected with CMV. Treatment with ganciclovir or cidofovir resulted in a significant suppression of CMV replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15196821     DOI: 10.1016/j.antiviral.2004.02.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

Review 1.  The search for new therapies for human cytomegalovirus infections.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Virus Res       Date:  2010-11-21       Impact factor: 3.303

2.  Impaired surfactant production by alveolar epithelial cells in a SCID-hu lung mouse model of congenital human cytomegalovirus infection.

Authors:  Ekaterina Maidji; Galina Kosikova; Pheroze Joshi; Cheryl A Stoddart
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

Review 3.  The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis.

Authors:  S H James; M N Prichard
Journal:  Infect Disord Drug Targets       Date:  2011-10

4.  Granulocyte-colony stimulating factor reactivates human cytomegalovirus in a latently infected humanized mouse model.

Authors:  M Shane Smith; Devorah C Goldman; Alexis S Bailey; Dana L Pfaffle; Craig N Kreklywich; Doran B Spencer; Florence A Othieno; Daniel N Streblow; J Victor Garcia; William H Fleming; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

5.  Infection of human cytomegalovirus in cultured human gingival tissue.

Authors:  Rong Hai; Alice Chu; Hongjian Li; Sean Umamoto; Paul Rider; Fenyong Liu
Journal:  Virol J       Date:  2006-10-05       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.